Corbus Pharmaceuticals Holdings Inc. Stock Slips 4.2%, Underperforms Peers

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Corbus Pharmaceuticals Holdings Inc. slipped 4.2% to $6.63 on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index falling 0.1% to 26,797.54 and Dow Jones Industrial Average falling 0.3% to 51,349.92.

This was the stock's fifth consecutive day of losses.

Corbus Pharmaceuticals Holdings Inc. closed 67.8% short of its 52-week high of $20.56, which the company achieved on October 20th.

The stock underperformed when compared to some of its peers, as Vanda Pharmaceuticals Inc. fell 2.7% to $5.03, Fortress Biotech Inc. rose 1.4% to $2.20, and Viking Therapeutics Inc. fell 3.69% to $31.81.

Trading volume totaled 785,025, compared to the 50-day average of 795,688.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

September 29, 2026 16:34 ET (20:34 GMT)